TOCA stock forecast
Our latest prediction for Tocagen, Inc.'s stock price was made on the May 28, 2019 when the stock price was at 4.32$.
In the short term (2weeks), TOCA's stock price should outperform the market by 6.44%. During that period the price should oscillate between -9.78% and +21.18%.
In the medium term (3months), TOCA's stock price should outperform the market by 4.57%. During that period the price should oscillate between -20.90% and +46.40%.Get email alerts
About Tocagen, Inc.
Tocagen, Inc. is a clinical-stage, cancer-selective gene therapy compan. It focuses on the development of product candidates designed to activate a patient's immune system against their own cancer from within. It is in the business of discovery, development, and commercialization of products for the treatment of cancer. The company was founded by Thomas E. Darcy, Harry E. Gruber, Douglas J. Jolly, and Dennis N. Berman in August 2007 and is headquartered San Diego, CA.
At the moment the company generates 18M USD in revenues.
On its last earning announcement, the company reported a loss of -2.52$ per share.
The book value per share is 2.31$
Three months stock forecastMay 28, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|